Yestar Healthcare Holdings Co Ltd(HK:2393)
HK$0.05+0.01 (+19.05%)
HK:2393
Yestar Healthcare Holdings Co Ltd financials statements
HK$0.05
At close:+0.01 (+19.05%)
Want to see HK:2393 full AI Analyst Report?
Yestar Healthcare Holdings Co Ltd (2393) Ratios
2 Followers
Yestar Healthcare Holdings Co Ltd Ratios
HK:2393's free cash flow for Q2 2026 was ¥3.87M. For the 2026 fiscal year, HK:2393's free cash flow was decreased by ¥-40.56M and operating cash flow was ¥44.43M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.37 | 1.35 | 0.77 | 0.71 | 1.31 |
| Quick Ratio | 1.08 | 1.00 | 0.69 | 0.60 | 1.14 |
| Cash Ratio | 0.35 | 0.12 | 0.05 | 0.08 | 0.27 |
| Solvency Ratio | -0.05 | 1.07 | 0.04 | -0.21 | 0.04 |
| Operating Cash Flow Ratio | 0.46 | 0.02 | 0.10 | -0.03 | 0.33 |
| Short-Term Operating Cash Flow Coverage | 1.93 | 0.05 | 0.25 | -0.05 | 1.56 |
| Net Current Asset Value | ¥ 143.43M | ¥ 164.26M | ¥ -957.57M | ¥ -1.21B | ¥ -903.07M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.18 | 0.22 | 0.48 | 0.56 | 0.39 |
| Debt-to-Equity Ratio | 0.56 | 0.69 | -3.56 | -4.64 | 2.37 |
| Debt-to-Capital Ratio | 0.36 | 0.41 | 1.39 | 1.27 | 0.70 |
| Long-Term Debt-to-Capital Ratio | 0.06 | 0.01 | 0.00 | 0.00 | 0.60 |
| Financial Leverage Ratio | 3.16 | 3.10 | -7.49 | -8.24 | 6.04 |
| Debt Service Coverage Ratio | 0.19 | -0.26 | 0.19 | 0.02 | 0.46 |
| Interest Coverage Ratio | 0.07 | -5.09 | 0.87 | -0.47 | 1.43 |
| Debt to Market Cap | 0.88 | 2.06 | 11.09 | 2.49 | 0.72 |
| Interest Debt Per Share | 0.10 | 0.15 | 0.52 | 0.93 | 0.82 |
| Net Debt to EBITDA | -0.47 | -4.30 | 3.78 | 83.78 | 3.82 |
| Profitability Margins | |||||
| Gross Profit Margin | 17.91% | 16.56% | 17.60% | 14.18% | 17.21% |
| EBIT Margin | 0.82% | -4.97% | 7.06% | -7.55% | 3.74% |
| EBITDA Margin | 3.38% | -2.15% | 12.94% | 0.68% | 6.41% |
| Operating Profit Margin | 0.05% | -6.38% | 4.93% | -4.56% | 3.71% |
| Pretax Profit Margin | -3.48% | 38.58% | 1.41% | -17.29% | 1.22% |
| Net Profit Margin | -5.04% | 38.24% | -0.48% | -35.38% | 0.07% |
| Continuous Operations Profit Margin | -4.64% | 37.47% | 0.05% | -16.90% | 0.26% |
| Net Income Per EBT | 144.79% | 99.14% | -33.84% | 204.68% | 5.55% |
| EBT Per EBIT | -6721.01% | -605.01% | 28.58% | 378.80% | 32.73% |
| Return on Assets (ROA) | -6.28% | 64.44% | -0.41% | -29.45% | 0.07% |
| Return on Equity (ROE) | -19.84% | 199.66% | 3.04% | 242.68% | 0.44% |
| Return on Capital Employed (ROCE) | 0.15% | -24.59% | -48.64% | 98.34% | 7.64% |
| Return on Invested Capital (ROIC) | 0.11% | -16.22% | 0.40% | -7.72% | 1.33% |
| Return on Tangible Assets | -7.14% | 75.20% | -0.44% | -33.18% | 0.10% |
| Earnings Yield | -35.47% | 678.41% | -9.80% | -146.04% | 0.15% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.10 | 4.14 | 4.22 | 1.79 | 3.10 |
| Payables Turnover | 5.90 | 8.72 | 5.93 | 5.38 | 6.21 |
| Inventory Turnover | 6.29 | 7.15 | 8.11 | 8.79 | 11.13 |
| Fixed Asset Turnover | 13.20 | 19.94 | 11.28 | 6.49 | 10.72 |
| Asset Turnover | 1.25 | 1.69 | 0.85 | 0.83 | 1.08 |
| Working Capital Turnover Ratio | 5.64 | -8.40 | -3.14 | -16.54 | 49.64 |
| Cash Conversion Cycle | 85.13 | 97.43 | 69.98 | 177.91 | 91.78 |
| Days of Sales Outstanding | 89.03 | 88.23 | 86.52 | 204.23 | 117.77 |
| Days of Inventory Outstanding | 58.00 | 51.06 | 44.98 | 41.54 | 32.79 |
| Days of Payables Outstanding | 61.89 | 41.85 | 61.52 | 67.86 | 58.78 |
| Operating Cycle | 147.03 | 139.29 | 131.50 | 245.77 | 150.55 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.13 | 0.01 | 0.11 | -0.04 | 0.30 |
| Free Cash Flow Per Share | 0.12 | -0.01 | 0.08 | -0.05 | 0.28 |
| Dividend Paid and CapEx Coverage Ratio | 14.21 | 0.32 | 4.15 | -3.85 | 14.40 |
| Capital Expenditure Coverage Ratio | 14.21 | 0.32 | 4.15 | -3.85 | 14.40 |
| Operating Cash Flow Coverage Ratio | 1.48 | 0.04 | 0.24 | -0.05 | 0.40 |
| Operating Cash Flow to Sales Ratio | 0.21 | 0.01 | 0.13 | -0.03 | 0.15 |
| Free Cash Flow Yield | 136.82% | -19.47% | 207.57% | -17.01% | 30.28% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.82 | 0.15 | -10.21 | -0.68 | 660.57 |
| Price-to-Sales (P/S) Ratio | 0.14 | 0.06 | 0.05 | 0.24 | 0.45 |
| Price-to-Book (P/B) Ratio | 0.56 | 0.29 | -0.31 | -1.66 | 2.91 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 0.73 | -5.14 | 0.48 | -5.88 | 3.30 |
| Price-to-Operating Cash Flow Ratio | 0.68 | 10.68 | 0.37 | -7.41 | 3.07 |
| Price-to-Earnings Growth (PEG) Ratio | 0.03 | -0.00 | 0.10 | 0.00 | -6.57 |
| Enterprise Value Multiple | 3.73 | -6.91 | 4.16 | 119.29 | 10.77 |
| Enterprise Value | 188.06M | 358.98M | 1.57B | 2.28B | 3.40B |
| EV to EBITDA | 3.73 | -6.91 | 4.16 | 119.29 | 10.77 |
| EV to Sales | 0.13 | 0.15 | 0.54 | 0.81 | 0.69 |
| EV to Free Cash Flow | 0.65 | -13.57 | 5.33 | -19.75 | 5.11 |
| EV to Operating Cash Flow | 0.60 | 28.22 | 4.04 | -24.88 | 4.76 |
| Tangible Book Value Per Share | 0.12 | 0.13 | -0.19 | -0.31 | -0.17 |
| Shareholders’ Equity Per Share | 0.16 | 0.20 | -0.13 | -0.18 | 0.32 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.33 | 0.03 | 0.96 | 0.02 | 0.79 |
| Revenue Per Share | 0.64 | 1.03 | 0.84 | 1.20 | 2.10 |
| Net Income Per Share | -0.03 | 0.40 | -0.00 | -0.43 | 0.00 |
| Tax Burden | 1.45 | 0.99 | -0.34 | 2.05 | 0.06 |
| Interest Burden | -4.24 | -7.76 | 0.20 | 2.29 | 0.33 |
| Research & Development to Revenue | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 |
| SG&A to Revenue | 0.16 | 0.15 | 0.09 | 0.07 | 0.07 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -6.01 | 0.01 | 4.55 | 0.09 | 214.97 |
Currency in CNY

